# Cécile Dorange

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/cecile-dorange/

## Facts

| Field | Value |
| --- | --- |
| Citations | 14,402 |
| Field | Coronary Interventions and Diagnostics |
| h-index | 29 |
| i10-index | 43 |
| Last Known Institution | Bristol-Myers Squibb (Belgium) |
| OpenAlex ID | https://openalex.org/A5108491859 |
| Works | 63 |

## Researcher papers

- [Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-nonsquamous-non-small-cell-lung-cancer/)
- [A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods](https://scholariq.org/papers/a-bioabsorbable-everolimus-eluting-coronary-stent-system-absorb-2-year-outcomes/)
- [Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis](https://scholariq.org/papers/evaluation-of-the-second-generation-of-a-bioresorbable-everolimus-eluting/)

## Researcher topics

- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.